Fluviral

BIOLOGICAL4 trials

Sponsors

GlaxoSmithKline, Ottawa Hospital Research Institute, Mount Sinai Hospital, Canada, Dalhousie University

Conditions

HIVInfluenzaInfluenza VaccinesSeasonal Influenza

Phase 2

Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children

CompletedNCT01180621

Dalhousie UniversitySeasonal Influenza

Start: 2010-09-30End: 2011-04-30Updated: 2011-06-22

Phase 3

Influenza Vaccine in HIV

CompletedNCT00764998

Ottawa Hospital Research InstituteHIV, Influenza

Start: 2008-10-31End: 2009-08-31Updated: 2017-04-28

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

CompletedNCT00784784

Mount Sinai Hospital, CanadaInfluenza

Start: 2008-11-30End: 2009-06-30Updated: 2014-11-21

Phase 4

A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk

CompletedNCT00586469

GlaxoSmithKlineInfluenza Vaccines

Start: 2007-12-14End: 2008-01-14Updated: 2019-06-27

Related Papers

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

2012-03-3012 citations

The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.

2011-12-0614 citations

Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults.

2011-03-2534 citations